In 2019, the first CRISPR clinical trials were conducted to treat sickle cell diseases and in 2020, this treatment was ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

A discovery about the mechanisms that enable the immune system to sustain long-term protection could revolutionize treatment for chronic disease and cancer.

Complementary discoveries have the potential to enhance treatment options for antibiotic-resistant infections. Researchers at ...

Today's medical AI systems represent not just a new diagnostic tool, but a new kind of medical reasoning altogether, writes ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

Learn more about whether Natera, Inc. or Vertex Pharmaceuticals Incorporated is a better investment based on AAII's A+ ...

"This type of gene editing should also allow for the treatment of diseases whose origin is not genetic or whose origin cannot ...

Research in genetics and biotechnology has advanced by leaps and bounds in recent years, offering new hope for the treatment ...

Riding recent momentum in the Duchenne muscular dystrophy space, Capricor Therapeutics, Wave Life Sciences, Regenxbio and ...